Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines.
Zhang
Linna
L
Texas Children's Cancer Center, Houston, TX 77030, USA.
Plon
Sharon E
SE
Nuchtern
Jed G
JG
Burlingame
Susan
S
Blaney
Susan
S
Rousseau
Raphael
R
Berg
Stacey
S
D002453:Cell Cycle / Q000187:drug effects; D002945:Cisplatin / Q000633:toxicity*; D019938:Cyclin D1 / Q000096:biosynthesis*; D056742:Cyclin D2; D056743:Cyclin D3; D051358:Cyclin-Dependent Kinase 4; D051361:Cyclin-Dependent Kinase 6; D018844:Cyclin-Dependent Kinases / Q000096:biosynthesis; D016213:Cyclins / Q000096:biosynthesis*; D006801:Humans; D020128:Inhibitory Concentration 50; D009447:Neuroblastoma / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology*; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis; D016160:Retinoblastoma Protein / Q000096:biosynthesis; D014407:Tumor Cells, Cultured
C080336:CCND2 protein, human; C534696:CCND3 protein, human; D056742:Cyclin D2; D056743:Cyclin D3; D016213:Cyclins; D011518:Proto-Oncogene Proteins; D016160:Retinoblastoma Protein; D019938:Cyclin D1; C495900:CDK4 protein, human; C495911:CDK6 protein, human; D051358:Cyclin-Dependent Kinase 4; D051361:Cyclin-Dependent Kinase 6; D018844:Cyclin-Dependent Kinases; D002945:Cisplatin